1
|
Peters N, Trier Taasti V, Ackermann B, Bolsi A, Vallhagen Dahlgren C, Ellerbrock M, Fracchiolla F, Gomà C, Góra J, Cambraia Lopes P, Rinaldi I, Salvo K, Sojat Tarp I, Vai A, Bortfeld T, Lomax A, Richter C, Wohlfahrt P. Consensus guide on CT-based prediction of stopping-power ratio using a Hounsfield look-up table for proton therapy. Radiother Oncol 2023; 184:109675. [PMID: 37084884 PMCID: PMC10351362 DOI: 10.1016/j.radonc.2023.109675] [Citation(s) in RCA: 16] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2022] [Revised: 03/08/2023] [Accepted: 04/10/2023] [Indexed: 04/23/2023]
Abstract
BACKGROUND AND PURPOSE Studies have shown large variations in stopping-power ratio (SPR) prediction from computed tomography (CT) across European proton centres. To standardise this process, a step-by-step guide on specifying a Hounsfield look-up table (HLUT) is presented here. MATERIALS AND METHODS The HLUT specification process is divided into six steps: Phantom setup, CT acquisition, CT number extraction, SPR determination, HLUT specification, and HLUT validation. Appropriate CT phantoms have a head- and body-sized part, with tissue-equivalent inserts in regard to X-ray and proton interactions. CT numbers are extracted from a region-of-interest covering the inner 70% of each insert in-plane and several axial CT slices in scan direction. For optimal HLUT specification, the SPR of phantom inserts is measured in a proton beam and the SPR of tabulated human tissues is computed stoichiometrically at 100 MeV. Including both phantom inserts and tabulated human tissues increases HLUT stability. Piecewise linear regressions are performed between CT numbers and SPRs for four tissue groups (lung, adipose, soft tissue, and bone) and then connected with straight lines. Finally, a thorough but simple validation is performed. RESULTS The best practices and individual challenges are explained comprehensively for each step. A well-defined strategy for specifying the connection points between the individual line segments of the HLUT is presented. The guide was tested exemplarily on three CT scanners from different vendors, proving its feasibility. CONCLUSION The presented step-by-step guide for CT-based HLUT specification with recommendations and examples can contribute to reduce inter-centre variations in SPR prediction.
Collapse
Affiliation(s)
- Nils Peters
- OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Germany; Massachusetts General Hospital and Harvard Medical School, Department of Radiation Oncology, Boston, MA, USA.
| | - Vicki Trier Taasti
- Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands.
| | - Benjamin Ackermann
- Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany
| | - Alessandra Bolsi
- Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland
| | | | - Malte Ellerbrock
- Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany
| | - Francesco Fracchiolla
- Azienda Provinciale per i Servizi Sanitari (APSS) Protontherapy Department, Trento, Italy
| | - Carles Gomà
- Department of Radiation Oncology, Hospital Clínic de Barcelona, Barcelona, Spain
| | - Joanna Góra
- MedAustron Ion Therapy Center, Wiener Neustadt, Austria
| | | | - Ilaria Rinaldi
- Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands
| | - Koen Salvo
- AZ Sint-Maarten, Department of Radiotherapy, Mechelen, Belgium
| | - Ivanka Sojat Tarp
- Aarhus University Hospital, Danish Center for Particle Therapy, Aarhus, Denmark
| | - Alessandro Vai
- Radiotherapy Department, Center for National Oncological Hadrontherapy (CNAO), 27100 Pavia, Italy
| | - Thomas Bortfeld
- Massachusetts General Hospital and Harvard Medical School, Department of Radiation Oncology, Boston, MA, USA
| | - Antony Lomax
- Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland
| | - Christian Richter
- OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Germany; Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiooncology - OncoRay, Dresden, Germany; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; German Cancer Consortium (DKTK), partner site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - Patrick Wohlfahrt
- Massachusetts General Hospital and Harvard Medical School, Department of Radiation Oncology, Boston, MA, USA
| |
Collapse
|
2
|
Marques JB, Renha SK, Mendonça Pereira H, Lima TVM, Simões RFP. Effects of convolution filter with beam hardening correction on computed tomography image quality. Phys Med 2023; 110:102599. [PMID: 37167777 DOI: 10.1016/j.ejmp.2023.102599] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/23/2022] [Revised: 03/28/2023] [Accepted: 04/30/2023] [Indexed: 05/13/2023] Open
Abstract
PURPOSE To quantify the effects of convolution filters (FC) with beam hardening correction (BHC) compared to FC without BHC on the computed tomography (CT) image quality. METHODS This study was conducted on a Canon® Aquilion Lightning scanner. The exposure protocol includes acquisitions at 120 and 100 kVp. Sixteen FCs (8 with and 8 without BHC) were investigated using a Catphan®504 phantom. Uniformity, slice thickness, spatial resolution, Hounsfield unit and noise were analysed using the SPICE-CT ImageJ plugin and the noise power spectrum was analysed using the Imquest software. RESULTS It was observed that the BHC did not significantly influence the uniformity, slice thickness, noise and noise power spectrum. Comparisons of 10% MTF between FC01 and FC11 showed relative differences of -29% and -5% at 120 and 100 kVp, respectively, while those between FC09 and FC19 were -55% and -25%. The Hounsfield unit of the Catphan's region of highest electron density was reduced by -7.29% at 120 kVp for FC with BHC. In both cases (FC with and without BHC), the noise values agreed with CT operating manual. At 120 kVp, FC11 and FC09 presented the maximum and minimum noise values, respectively. CONCLUSION In CT procedures that quantitatively evaluate the bone or calcium Hounsfield unit, FC with BHC should be avoided due to its effects on Hounsfield units, in special at higher voltage, such as 120 kVp.
Collapse
Affiliation(s)
| | - Simone Kodlulovich Renha
- Institute of Radioprotection and Dosimetry, National Nuclear Energy Commission, Rio de Janeiro, Brazil
| | - Hélcio Mendonça Pereira
- Department of Medical Imaging, Brazilian National Institute of Orthopedics and Traumatology, Rio de Janeiro, Brazil; Department of Medical Imaging, Brazilian National Cancer Institute, Rio de Janeiro, Brazil
| | - Thiago Viana Miranda Lima
- Radiology and Nuclear Medicine, Luzerner Kantonsspital, Lucern, Switzerland; Department of Health Science and Medicine, University of Lucerne, Luzern, Switzerland
| | | |
Collapse
|
3
|
Young HM, Sun Park CK, Chau OW, Lee TY, Gaede S. Technical Note: Volumetric computed tomography for radiotherapy simulation and treatment planning. J Appl Clin Med Phys 2021; 22:295-302. [PMID: 34240548 PMCID: PMC8364284 DOI: 10.1002/acm2.13336] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2021] [Revised: 04/07/2021] [Accepted: 05/29/2021] [Indexed: 11/21/2022] Open
Abstract
Purpose For lung and liver tumors requiring radiotherapy, motion artifacts are common in 4D‐CT images due to the small axial field‐of‐view (aFOV) of conventional CT scanners. This may negatively impact contouring and dose calculation accuracy and could lead to a geographic miss during treatment. Recent advancements in volumetric CT (vCT) enable an aFOV up to 160 mm in a single rotation, which may reduce motion artifacts. However, the impact of large aFOV on CT number required for dose calculation needs to be evaluated before clinical implementation. The objective of this study was to determine the utility of a 256‐slice vCT scanner for 4D‐CT simulation by evaluating image quality and generating relative electron density (RED) curves. Methods Images were acquired on a 256‐slice GE Revolution CT scanner with 40 mm, 80 mm, 120 mm, 140 mm, and 160 mm aFOV. Image quality was assessed by evaluating CT number linearity, uniformity, noise, and low‐contrast resolution. The relationship between each quality metric and aFOV was assessed. Results CT number linearity, uniformity, noise, and low‐contrast resolution were within the expected range for each image set, except CT number in Teflon and Delrin, which were underestimated. Spearman correlation coefficient (ρ) showed that the CT number for Teflon (ρ = 1.0, p = 0.02), Delrin (ρ = 1.0, p = 0.02), and air (ρ = 1.0, p = 0.02) was significantly related to aFOV, while all other measurements were not. The measured deviations from expected values were not clinically significant. Conclusion These results suggest that vCT can be used for CT simulation for radiation treatment planning.
Collapse
Affiliation(s)
- Heather M Young
- Department of Medical Biophysics, University of Western Ontario, London, Canada.,London Regional Cancer Program, London, Canada.,Robarts Research Institute, University of Western Ontario, London, Canada
| | - Claire Keun Sun Park
- Department of Medical Biophysics, University of Western Ontario, London, Canada.,Robarts Research Institute, University of Western Ontario, London, Canada
| | - Oi-Wai Chau
- Department of Medical Biophysics, University of Western Ontario, London, Canada.,London Regional Cancer Program, London, Canada
| | - Ting-Yim Lee
- Department of Medical Biophysics, University of Western Ontario, London, Canada.,Robarts Research Institute, University of Western Ontario, London, Canada.,Lawson Health Research Institute, London, Canada
| | - Stewart Gaede
- Department of Medical Biophysics, University of Western Ontario, London, Canada.,London Regional Cancer Program, London, Canada.,Lawson Health Research Institute, London, Canada
| |
Collapse
|